Outcomes and predictors of seizure recurrence in post-stroke epilepsy, a retrospective hospital-based study

The occurrence of seizures following a stroke is a well-recognized complication associated with a significant increase in morbidity and mortality. Despite the numerous studies examining outcomes and risk factors related to post-stroke seizures (PSS), there remains a lack of clarity regarding the cli...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical neurology and neurosurgery 2024-04, Vol.239, p.108208-108208, Article 108208
Hauptverfasser: Shariff, Erum, Nazish, Saima, Shahid, Rizwana, Zafar, Azra, Yasawy, Zakia M., AlKhaldi, Norah A., AlJaafari, Danah, Soltan, Nehad M., Alshamrani, Foziah, AlShurem, Mohammed, Albakr, Aishah Ibrahim, AlSulaiman, Feras, Alameri, Rana, Alabdali, Majed
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The occurrence of seizures following a stroke is a well-recognized complication associated with a significant increase in morbidity and mortality. Despite the numerous studies examining outcomes and risk factors related to post-stroke seizures (PSS), there remains a lack of clarity regarding the clinical characteristics, treatment, and PSS recurrence (PSSR) rates in patients experiencing their initial episode of PSS. This study aimed to determine the risk factors for developing recurrent seizures after first PSS and their effects on functional outcomes and mortality. All patients underwent an electroencephalography (EEG) and were monitored for a minimum of 24 months following the first PSS. The primary endpoint was the recurrence of seizures. Predictive factors for PSSR were determined by using the Cox-proportional hazards model, and the cumulative latency of recurrence at 90, 180, 360, and 720 days was estimated using Kaplan-Meier analysis. Seizure recurred in 36.8% (39/106). Significant association of PSSR was noted with female gender, use of older anti-seizure medications (ASMs) (p
ISSN:0303-8467
1872-6968
DOI:10.1016/j.clineuro.2024.108208